OpenURL Connection Search

Select item for more details and to access through your institution.

Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis.
Published in:
2022
By:
- Patt, Debra;
- Xianchen Liu;
- Li, Benjamin;
- McRoy, Lynn;
- Layman, Rachel M.;
- Brufsky, Adam;
- Liu, Xianchen
Publication type:
journal article
Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer.
Published in:
Clinical Breast Cancer, 2011, v. 11, n. 4, p. 221, doi. 10.1016/j.clbc.2011.03.022
By:
- Lustberg, Maryam B.;
- Povoski, Stephen P.;
- Zhao, Weiqiang;
- Ziegler, Rebecca M.;
- Sugimoto, Yasuro;
- Ruppert, Amy S.;
- Lehman, Amy M.;
- Shiels, Donna R.;
- Mrozek, Ewa;
- Ramaswamy, Bhuvaneswari;
- Layman, Rachel M.;
- Brueggemeier, Robert W.;
- Shapiro, Charles L.
Publication type:
Article
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer.
Published in:
Breast Cancer Research & Treatment, 2024, v. 204, n. 2, p. 289, doi. 10.1007/s10549-023-07195-5
By:
- Nakhlis, Faina;
- Niman, Samuel M.;
- Ueno, Naoto T.;
- Troll, Elizabeth;
- Ryan, Sean;
- Yeh, Eren;
- Warren, Laura;
- Bellon, Jennifer;
- Harrison, Beth;
- Iwase, Toshiaki;
- Carisa Le-Petross, H. T.;
- Saleem, Sadia;
- Teshome, Mediget;
- Whitman, Gary J.;
- Woodward, Wendy A.;
- Overmoyer, Beth;
- Tolaney, Sara M.;
- Regan, Meredith;
- Lynce, Filipa;
- Layman, Rachel M.
Publication type:
Article
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer.
Published in:
Breast Cancer Research & Treatment, 2023, v. 199, n. 3, p. 457, doi. 10.1007/s10549-023-06929-9
By:
- Yam, Clinton;
- Mittendorf, Elizabeth A.;
- Garber, Haven R.;
- Sun, Ryan;
- Damodaran, Senthil;
- Murthy, Rashmi K.;
- Ramirez, David;
- Karuturi, Meghan;
- Layman, Rachel M.;
- Ibrahim, Nuhad;
- Rauch, Gaiane M.;
- Adrada, Beatriz E.;
- Candelaria, Rosalind P.;
- White, Jason B.;
- Ravenberg, Elizabeth;
- Clayborn, Alyson;
- Ding, Qing Qing;
- Symmans, W. Fraser;
- Prabhakaran, Sabitha;
- Thompson, Alastair M.
Publication type:
Article
Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.
Published in:
Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 253, doi. 10.1007/s10549-022-06572-w
By:
- Mouabbi, Jason A.;
- Hassan, Amy;
- Lim, Bora;
- Hortobagyi, Gabriel N.;
- Tripathy, Debasish;
- Layman, Rachel M.
Publication type:
Article
Advanced stage breast cancer is associated with catheter-tip thrombus formation following implantable central venous port placement.
Published in:
Phlebology, 2019, v. 34, n. 2, p. 107, doi. 10.1177/0268355518774442
By:
- Makary, Mina S.;
- Lionberg, Alexander;
- Khayat, Mamdouh;
- Lustberg, Maryam B.;
- AlTaani, Jamal;
- Pan, Xueliang J.;
- Layman, Richard R.;
- Raman, Subha V.;
- Layman, Rachel M.;
- Dowell, Joshua D.
Publication type:
Article
Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1237751
By:
- Brufsky, Adam;
- Xianchen Liu;
- Li, Benjamin;
- McRoy, Lynn;
- Chen, Connie;
- Layman, Rachel M.;
- Rugo, Hope S.
Publication type:
Article
ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.
Published in:
2022
By:
- Cobb, Adrienne N.;
- Diao, Kevin;
- Teshome, Mediget;
- Lucci, Anthony;
- Ueno, Naoto T.;
- Stauder, Michael;
- Layman, Rachel M.;
- Kuerer, Henry M.;
- Woodward, Wendy A.;
- Sun, Susie X.
Publication type:
Abstract
Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 10, p. 6381, doi. 10.1245/s10434-022-12144-5
By:
- Cobb, Adrienne N.;
- Diao, Kevin;
- Teshome, Mediget;
- Lucci, Anthony;
- Ueno, Naoto T.;
- Stauder, Michael;
- Layman, Rachel M.;
- Kuerer, Henry M.;
- Woodward, Wendy A.;
- Sun, Susie X.
Publication type:
Article
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC.
Published in:
2020
By:
- Iwase, Toshiaki;
- Harano, Kenichi;
- Masuda, Hiroko;
- Kida, Kumiko;
- Hess, Kenneth R.;
- Wang, Ying;
- Dirix, Luc;
- Van Laere, Steven J.;
- Lucci, Anthony;
- Krishnamurthy, Savitri;
- Woodward, Wendy A.;
- Layman, Rachel M.;
- Bertucci, François;
- Ueno, Naoto T.
Publication type:
journal article
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.
Published in:
2020
By:
- Wesolowski, Robert;
- Stiff, Andrew;
- Quiroga, Dionisia;
- McQuinn, Christopher;
- Li, Zaibo;
- Nitta, Hiroaki;
- Savardekar, Himanshu;
- Benner, Brooke;
- Ramaswamy, Bhuvaneswari;
- Lustberg, Maryam;
- Layman, Rachel M.;
- Macrae, Erin;
- Kassem, Mahmoud;
- Williams, Nicole;
- Sardesai, Sagar;
- VanDeusen, Jeffrey;
- Stover, Daniel;
- Cherian, Mathew;
- Mace, Thomas A.;
- Yu, Lianbo
Publication type:
journal article
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.
Published in:
Investigational New Drugs, 2023, v. 41, n. 3, p. 391, doi. 10.1007/s10637-023-01357-4
By:
- Abuhadra, Nour;
- Sun, Ryan;
- Bassett Jr, Roland L.;
- Huo, Lei;
- Chang, Jeffrey T.;
- Teshome, Mediget;
- Clayborn, Alyson R.;
- White, Jason B.;
- Ravenberg, Elizabeth E.;
- Adrada, Beatriz E.;
- Candelaria, Rosalind P.;
- Yang, Wei;
- Ding, Qingqing;
- Symmans, W. Fraser;
- Arun, Banu;
- Damodaran, Senthil;
- Koenig, Kimberly B.;
- Layman, Rachel M.;
- Lim, Bora;
- Litton, Jennifer K.
Publication type:
Article
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice.
Published in:
2021
By:
- DeMichele, Angela;
- Cristofanilli, Massimo;
- Brufsky, Adam;
- Liu, Xianchen;
- Mardekian, Jack;
- McRoy, Lynn;
- Layman, Rachel M.;
- Emir, Birol;
- Torres, Mylin A.;
- Rugo, Hope S.;
- Finn, Richard S.
Publication type:
journal article
Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice.
Published in:
Cancers, 2023, v. 15, n. 21, p. 5268, doi. 10.3390/cancers15215268
By:
- Brufsky, Adam;
- Liu, Xianchen;
- Li, Benjamin;
- McRoy, Lynn;
- Chen, Connie;
- Layman, Rachel M.;
- Rugo, Hope S.
Publication type:
Article
Survival Outcomes in Patients With Hormone Receptor–Positive Metastatic Breast Cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy.
Published in:
JAMA Network Open, 2023, v. 6, n. 5, p. e2313017, doi. 10.1001/jamanetworkopen.2023.13017
By:
- Mouabbi, Jason A.;
- Singareeka Raghavendra, Akshara;
- Bassett Jr, Roland L.;
- Hassan, Amy;
- Tripathy, Debasish;
- Layman, Rachel M.
Publication type:
Article
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer.
Published in:
Cancer Medicine, 2022, v. 11, n. 6, p. 1474, doi. 10.1002/cam4.4566
By:
- Layman, Rachel M.;
- Lin, Heather;
- Barrera, Angelica M. Gutierrez;
- Karuturi, Meghan S.;
- Yam, Clinton;
- Arun, Banu K.
Publication type:
Article
Real‐world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron Database.
Published in:
International Journal of Cancer, 2024, v. 154, n. 4, p. 701, doi. 10.1002/ijc.34748
By:
- Rugo, Hope S.;
- Liu, Xianchen;
- Li, Benjamin;
- McRoy, Lynn;
- Chen, Connie;
- Layman, Rachel M.;
- Brufsky, Adam
Publication type:
Article
Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2− metastatic breast cancer patients compared to endocrine therapy alone in the second‐line setting: A large institutional study.
Published in:
International Journal of Cancer, 2022, v. 150, n. 12, p. 2025, doi. 10.1002/ijc.33959
By:
- Ha, Min Jin;
- Singareeka Raghavendra, Akshara;
- Kettner, Nicole M.;
- Qiao, Wei;
- Damodaran, Senthil;
- Layman, Rachel M.;
- Hunt, Kelly K.;
- Shen, Yu;
- Tripathy, Debu;
- Keyomarsi, Khandan
Publication type:
Article
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
Published in:
2014
By:
- Lustberg, Maryam B;
- Balasubramanian, Priya;
- Miller, Brandon;
- Garcia-Villa, Alejandra;
- Deighan, Clayton;
- Wu, Yongqi;
- Carothers, Sarah;
- Berger, Michael;
- Ramaswamy, Bhuvaneswari;
- Macrae, Erin R;
- Wesolowski, Robert;
- Layman, Rachel M;
- Mrozek, Ewa;
- Pan, Xueliang;
- Summers, Thomas A;
- Shapiro, Charles L;
- Chalmers, Jeffrey J
Publication type:
journal article
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
Published in:
Breast Cancer Research, 2014, v. 16, n. 2, p. 1, doi. 10.1186/bcr3622
By:
- Lustberg, Maryam B.;
- Balasubramanian, Priya;
- Miller, Brandon;
- Garcia-Villa, Alejandra;
- Deighan, Clayton;
- Yongqi Wu;
- Carothers, Sarah;
- Berger, Michael;
- Ramaswamy, Bhuvaneswari;
- Macrae, Erin R.;
- Wesolowski, Robert;
- Layman, Rachel M.;
- Mrozek, Ewa;
- Xueliang Pan;
- Summers, Thomas A.;
- Shapiro, Charles L.;
- Chalmers, Jeffrey J.
Publication type:
Article
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.
Published in:
Breast Journal, 2020, v. 26, n. 8, p. 1572, doi. 10.1111/tbj.13922
By:
- Bayraktar, Soley;
- Zhou, Jade Z.;
- Bassett, Roland;
- Gutierrez Barrera, Angelica M.;
- Layman, Rachel M.;
- Valero, Vicente;
- Arun, Banu
Publication type:
Article
Correction to: Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice.
Published in:
2021
By:
- Brufsky, Adam;
- Liu, Xianchen;
- Li, Benjamin;
- McRoy, Lynn;
- Layman, Rachel M.
Publication type:
Correction Notice
Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice.
Published in:
Targeted Oncology, 2021, v. 16, n. 5, p. 601, doi. 10.1007/s11523-021-00826-1
By:
- Brufsky, Adam;
- Liu, Xianchen;
- Li, Benjamin;
- McRoy, Lynn;
- Layman, Rachel M.
Publication type:
Article
Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions.
Published in:
2018
By:
- Vijayaraghavan, Smruthi;
- Moulder, Stacy;
- Keyomarsi, Khandan;
- Layman, Rachel M.
Publication type:
journal article
Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies.
Published in:
NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00499-7
By:
- Mouabbi, Jason A.;
- Raghavendra, Akshara Singareeka;
- Bassett Jr, Roland L.;
- Hassan, Amy;
- Tripathy, Debu;
- Layman, Rachel M.
Publication type:
Article
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer.
Published in:
NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00479-x
By:
- Rugo, Hope S.;
- Brufsky, Adam;
- Liu, Xianchen;
- Li, Benjamin;
- McRoy, Lynn;
- Chen, Connie;
- Layman, Rachel M.;
- Cristofanilli, Massimo;
- Torres, Mylin A.;
- Curigliano, Giuseppe;
- Finn, Richard S.;
- DeMichele, Angela
Publication type:
Article
Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma.
Published in:
Oncologist, 2024, v. 29, n. 3, p. 213, doi. 10.1093/oncolo/oyad317
By:
- Mouabbi, Jason A;
- Qaio, Wei;
- Shen, Yu;
- Raghavendra, Akshara Singareeka;
- Tripathy, Debasish;
- Layman, Rachel M
Publication type:
Article
Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer.
Published in:
Oncologist, 2023, v. 28, n. 10, p. 866, doi. 10.1093/oncolo/oyad209
By:
- Rugo, Hope S;
- Liu, Xianchen;
- Li, Benjamin;
- McRoy, Lynn;
- Chen, Connie;
- Layman, Rachel M;
- Brufsky, Adam
Publication type:
Article
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study.
Published in:
Oncologist, 2020, v. 25, n. 8, p. e1158, doi. 10.1634/theoncologist.2020-0039
By:
- Wesolowski, Robert;
- Stover, Daniel G.;
- Lustberg, Maryam B.;
- Shoben, Abigail;
- Zhao, Meng;
- Mrozek, Ewa;
- Layman, Rachel M.;
- Macrae, Erin;
- Duan, Wenrui;
- Zhang, Jun;
- Hall, Nathan;
- Wright, Chadwick L.;
- Gillespie, Susan;
- Berger, Michael;
- Chalmers, Jeffrey J.;
- Carey, Alahdra;
- Balasubramanian, Priya;
- Miller, Brandon L.;
- Amaya, Peter;
- Andreopoulou, Eleni
Publication type:
Article
Real-World Effectiveness of Palbociclib Plus Letrozole vs Letrozole Alone for Metastatic Breast Cancer With Lung or Liver Metastases: Flatiron Database Analysis.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.865292
By:
- Brufsky, Adam;
- Xianchen Liu;
- Benjamin Li;
- Lynn McRoy;
- Layman, Rachel M.
Publication type:
Article

Found: 30